BAX
Price
$24.16
Change
-$0.53 (-2.15%)
Updated
Sep 2, 04:13 PM (EDT)
Capitalization
12.68B
58 days until earnings call
STE
Price
$242.08
Change
-$2.98 (-1.22%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
24.14B
69 days until earnings call
Interact to see
Advertisement

BAX vs STE

Header iconBAX vs STE Comparison
Open Charts BAX vs STEBanner chart's image
Baxter International
Price$24.16
Change-$0.53 (-2.15%)
Volume$22.77K
Capitalization12.68B
STERIS
Price$242.08
Change-$2.98 (-1.22%)
Volume$2.32K
Capitalization24.14B
BAX vs STE Comparison Chart in %
Loading...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAX vs. STE commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a Hold and STE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (BAX: $24.69 vs. STE: $245.06)
Brand notoriety: BAX and STE are both not notable
BAX represents the Pharmaceuticals: Other, while STE is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BAX: 55% vs. STE: 94%
Market capitalization -- BAX: $12.68B vs. STE: $24.14B
BAX [@Pharmaceuticals: Other] is valued at $12.68B. STE’s [@Medical/Nursing Services] market capitalization is $24.14B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.67B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.89B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.98B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAX’s FA Score shows that 2 FA rating(s) are green whileSTE’s FA Score has 0 green FA rating(s).

  • BAX’s FA Score: 2 green, 3 red.
  • STE’s FA Score: 0 green, 5 red.
According to our system of comparison, STE is a better buy in the long-term than BAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAX’s TA Score shows that 5 TA indicator(s) are bullish while STE’s TA Score has 3 bullish TA indicator(s).

  • BAX’s TA Score: 5 bullish, 3 bearish.
  • STE’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, BAX is a better buy in the short-term than STE.

Price Growth

BAX (@Pharmaceuticals: Other) experienced а +1.32% price change this week, while STE (@Medical/Nursing Services) price change was -2.70% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.03%. For the same industry, the average monthly price growth was +8.26%, and the average quarterly price growth was +29.93%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.44%. For the same industry, the average monthly price growth was +3.05%, and the average quarterly price growth was +13.14%.

Reported Earning Dates

BAX is expected to report earnings on Oct 30, 2025.

STE is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.03% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-0.44% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STE($24.1B) has a higher market cap than BAX($12.7B). BAX has higher P/E ratio than STE: BAX (87.85) vs STE (37.47). STE YTD gains are higher at: 19.805 vs. BAX (-13.843). BAX has more cash in the bank: 1.8B vs. STE (280M). STE has less debt than BAX: STE (2.07B) vs BAX (10.3B).
BAXSTEBAX / STE
Capitalization12.7B24.1B53%
EBITDAN/A1.41B-
Gain YTD-13.84319.805-70%
P/E Ratio87.8537.47234%
RevenueN/A5.57B-
Total Cash1.8B280M644%
Total Debt10.3B2.07B498%
FUNDAMENTALS RATINGS
BAX vs STE: Fundamental Ratings
BAX
STE
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
57
Fair valued
PROFIT vs RISK RATING
1..100
10043
SMR RATING
1..100
9271
PRICE GROWTH RATING
1..100
6535
P/E GROWTH RATING
1..100
3164
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BAX's Valuation (20) in the Medical Specialties industry is somewhat better than the same rating for STE (57). This means that BAX’s stock grew somewhat faster than STE’s over the last 12 months.

STE's Profit vs Risk Rating (43) in the Medical Specialties industry is somewhat better than the same rating for BAX (100). This means that STE’s stock grew somewhat faster than BAX’s over the last 12 months.

STE's SMR Rating (71) in the Medical Specialties industry is in the same range as BAX (92). This means that STE’s stock grew similarly to BAX’s over the last 12 months.

STE's Price Growth Rating (35) in the Medical Specialties industry is in the same range as BAX (65). This means that STE’s stock grew similarly to BAX’s over the last 12 months.

BAX's P/E Growth Rating (31) in the Medical Specialties industry is somewhat better than the same rating for STE (64). This means that BAX’s stock grew somewhat faster than STE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAXSTE
RSI
ODDS (%)
Bullish Trend 5 days ago
63%
Bearish Trend 5 days ago
56%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
65%
Bearish Trend 5 days ago
50%
Momentum
ODDS (%)
Bullish Trend 5 days ago
53%
Bearish Trend 5 days ago
62%
MACD
ODDS (%)
Bullish Trend 5 days ago
58%
Bearish Trend 5 days ago
52%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
54%
Bearish Trend 5 days ago
56%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
64%
Bullish Trend 5 days ago
53%
Advances
ODDS (%)
Bullish Trend 9 days ago
51%
Bullish Trend 7 days ago
56%
Declines
ODDS (%)
Bearish Trend 13 days ago
61%
Bearish Trend 16 days ago
51%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
59%
Bearish Trend 5 days ago
68%
Aroon
ODDS (%)
Bearish Trend 5 days ago
57%
Bearish Trend 5 days ago
39%
View a ticker or compare two or three
Interact to see
Advertisement
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PALL101.170.33
+0.33%
abrdn Physical Palladium Shares ETF
RFFC62.70N/A
N/A
ALPS Active Equity Opportunity ETF
FFGX28.87-0.14
-0.49%
Fidelity Fundamental Global ex-U.S. ETF
FELG38.90-0.45
-1.14%
Fidelity Enhanced Large Cap Growth ETF
CNBS33.71-0.43
-1.27%
Amplify Seymour Cannabis ETF

BAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been loosely correlated with ALGN. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if BAX jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
+1.90%
ALGN - BAX
60%
Loosely correlated
+0.59%
LUNG - BAX
53%
Loosely correlated
-2.84%
STE - BAX
51%
Loosely correlated
+0.12%
SYK - BAX
51%
Loosely correlated
+0.45%
SOLV - BAX
50%
Loosely correlated
+0.59%
More

STE and

Correlation & Price change

A.I.dvisor indicates that over the last year, STE has been loosely correlated with SYK. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if STE jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STE
1D Price
Change %
STE100%
+0.12%
SYK - STE
55%
Loosely correlated
+0.45%
LH - STE
51%
Loosely correlated
+0.98%
RVTY - STE
49%
Loosely correlated
+0.99%
WAT - STE
49%
Loosely correlated
+1.39%
DHR - STE
49%
Loosely correlated
+0.26%
More